A Study of a Telemedicine Program for Older Adults With Cancer

Tele-Geriatric Oncology Program: Geriatric Assessment Via Telemedicine for Older Adults With Cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04917848

Enrollment

124

Registered

2021-06-08

Start date

2021-06-01

Completion date

2027-06-01

Last updated

2026-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Geriatric Oncology Program, Geriatric Assessment, Telemedicine, Tele-Geriatric Oncology Program, 21-200, Memorial Sloan Kettering Cancer Center

Brief summary

The purpose of this study is to find out if a telemedicine program for older adults in cancer treatment is a practical way to understand and meet these participants' unique needs. Telemedicine is the use of secure video technology on a desktop computer, laptop, smartphone, or tablet to provide and receive healthcare from a distance. The telemedicine program used in this study is called a tele-geriatric oncology program. It involves the participant and a study nurse meeting by videoconferencing during 2-6 telemedicine visits. As part of the program, the participant and the study nurse will discuss the participant's symptoms and aging-related needs.

Interventions

OTHERTele-Geriatric Oncology program

Participants will be scheduled to meet with a Geriatric Nurse Practitioner (GNP) or Geriatric Registered Nurse (GRN) via the program's telemedicine platform. The telemedicine encounters with the GNP/GRN may occur every 2 weeks over 3 months, for a total of 6 visits. Visits 1 and 6 are mandatory, and visits 2-5 are on an as needed basis.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

70 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age 70 or older * Gastrointestinal or gynecological cancer. * Receiving or about to receive medical cancer treatment (e.g., chemotherapy, immunotherapy, targeted therapy, biological agents)

Exclusion criteria

* Inability of the patient or caregiver to read or comprehend English * No internet connection at home * No electronic device with videoconferencing capability

Design outcomes

Primary

Measure	Time frame	Description
Feasibility of Tele-Geriatric Oncology Program	18 months	We will report the proportion (and CI) of optional telemedicine visits attended by enrolled participants out of the total number of scheduled optional telemedicine encounters. As participants could have multiple scheduled optional appointments and these appointments for the same participant would be correlated, the confidence interval will be calculated based on bootstrapping our original sample.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORBeatriz Korc-Grodzicki, MD, MPH

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 10, 2026